Diphenyleneiodonium Efficiently Inhibits the Characteristics of a Cancer Stem Cell Model Derived from Induced Pluripotent Stem Cells

Researchers employed miPS-Huh7cmP cells to reevaluate the efficacy of diphenyleneiodonium since CSCs are currently one of the main foci of therapeutic strategy to treat cancer, but generally considered resistant to chemotherapy.